- Trials with a EudraCT protocol (28,960)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
28,960 result(s) found for: Informed Consent.
Displaying page 595 of 1,448.
| EudraCT Number: 2009-018017-40 | Sponsor Protocol Number: NL0919 | Start Date*: 2010-06-09 | |||||||||||
| Sponsor Name:Reckitt Benckiser Healthcare UK Ltd | |||||||||||||
| Full Title: A randomised, double-blind, multi-centre, placebo controlled parallel group study to evaluate the efficacy and tolerability of a new Ibuprofen gel in patients with acute sports-related traumatic bl... | |||||||||||||
| Medical condition: Acute sports-related traumatic blunt soft tissue injury/contusion | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-001927-36 | Sponsor Protocol Number: 14/2007/U/Sper | Start Date*: 2007-04-23 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
| Full Title: Early ultrasonography role by Contrast enhanced ultrasonography ( CEUS) evaluating therapy effectiveness in patients with hepatic metastasis of colorectal cancer treated with antiangiogenetic drug. | |||||||||||||
| Medical condition: methastatic colorectal cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-001907-19 | Sponsor Protocol Number: PILOT-PREXOL | Start Date*: 2019-07-03 | |||||||||||
| Sponsor Name:Region Skåne | |||||||||||||
| Full Title: Pramipexole augmentation to target anhedonia in depression - a pilot study | |||||||||||||
| Medical condition: Depression | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-002081-40 | Sponsor Protocol Number: Repha_1431 | Start Date*: 2017-09-05 | |||||||||||
| Sponsor Name:Repha GmbH | |||||||||||||
| Full Title: Investigation of the efficacy and safety of ANGOCIN® Anti-Infekt N versus placebo in adult patients with acute, uncomplicated rhinosinusits. A multi-center, randomized, double-blind, placebo-contro... | |||||||||||||
| Medical condition: acute uncomplicated rhinosinusitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-003810-96 | Sponsor Protocol Number: 14-073 | Start Date*: 2015-01-15 |
| Sponsor Name:RWTH Aachen University for the Medical Falculty, represented by Clinical Trial Center Aachen (CTC-A) | ||
| Full Title: Emergence times and airway reactions in general laryngeal mask airway anesthesia: a randomized multicenter controlled trial | ||
| Medical condition: Under investigation are first the time a patient needs to emerge from anesthesia (stating the date of birth) and second the occurrence of airway complications. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-000913-35 | Sponsor Protocol Number: BECRO/OV/DORZO | Start Date*: 2019-05-21 | |||||||||||||||||||||
| Sponsor Name:BECRO (Cyprus) Ltd | |||||||||||||||||||||||
| Full Title: A Randomized, Observer-blind, two Parallel Group, Multi-center, Clinical Trial for Comparing the Efficacy and Tolerability of Dorzo-Vision® sine Preservative-Free Eye Drops vs. Trusopt® Preservativ... | |||||||||||||||||||||||
| Medical condition: Open angle glaucoma or ocular hypertension | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GR (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2018-002653-29 | Sponsor Protocol Number: NOMA | Start Date*: 2020-03-16 |
| Sponsor Name:FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE | ||
| Full Title: Multicenter, randomized, dose-finding, parallel, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of intramuscular administration of allogeneic mesenchymal cells de... | ||
| Medical condition: Critical ischemia of lower limbs in diabetic patients | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000545-52 | Sponsor Protocol Number: GLPG0634-CL-225 | Start Date*: 2017-10-06 | |||||||||||
| Sponsor Name:Galapagos Nv | |||||||||||||
| Full Title: A multicenter, open-label, long-term extension safety and efficacy study of filgotinib treatment in subjects with moderately to severely active psoriatic arthritis | |||||||||||||
| Medical condition: Psoriatic arthritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) CZ (Prematurely Ended) BG (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2012-003981-42 | Sponsor Protocol Number: 2012.2708 | Start Date*: 2014-10-20 |
| Sponsor Name:University Medical Center Groningen [...] | ||
| Full Title: Estrogen receptor and androgen receptor imaging in metastatic breast cancer patients | ||
| Medical condition: Estrogen receptor positive metastatic breast cancer patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-003865-20 | Sponsor Protocol Number: 21618 | Start Date*: 2021-03-02 | |||||||||||
| Sponsor Name:Bayer AG | |||||||||||||
| Full Title: A clinical trial collecting Data from routine ophthalmological examinations of patients who were randomized to either finerenone or placebo in the two Bayer-sponsored Phase 3 clinical trials FIDELI... | |||||||||||||
| Medical condition: Diabetic Retinopathy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-000559-35 | Sponsor Protocol Number: 0 | Start Date*: 2022-07-14 |
| Sponsor Name:None | ||
| Full Title: COMPLICATIONS AND DEGREE OF TOLERANCE OF THE ADMINISTRATION OF LOCAL ANESTHESIA IN DIAGNOSTIC / THERAPEUTIC THORACOCENTESIS PROCEDURES | ||
| Medical condition: There is no consensus about the most appropriate local anesthetic, and 1% mepicavain and 2% lidocaine uses can be postulated indistinctly. This project was born with the intention of highlighting t... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005440-17 | Sponsor Protocol Number: LOX_2015_PILOT | Start Date*: 2015-09-17 |
| Sponsor Name:Private Universität Witten/Herdecke gGmbH | ||
| Full Title: Tolerability and analgesic efficacy of Loxapine in patients with refractory, chemotherapy-induced neuropathic pain | ||
| Medical condition: Chemotherapy-induced neuropathic pain | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-023630-24 | Sponsor Protocol Number: Ev02 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:GMIHO mbH | |||||||||||||
| Full Title: Phase II open-label pilot study evaluating the safety and efficacy of Certican ® (everolimus) in the prevention of chronic graft-versus-host disease and late pulmonary complications after allogenei... | |||||||||||||
| Medical condition: Prevention of chronic graft-versus-host disease and late pulmonary complications after allogeneic hematopoietic stem cell transplantation blood | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-002226-22 | Sponsor Protocol Number: 2.0 | Start Date*: 2019-04-30 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: The Impact of Target Temperature Management on Drug Metabolism | ||
| Medical condition: Patients after successful cardiopulmonary resuscitation who undergo target temperature management for 24h hours | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002334-39 | Sponsor Protocol Number: RGH-MD-56 | Start Date*: 2012-04-09 | |||||||||||
| Sponsor Name:Forest Research Institute, Inc | |||||||||||||
| Full Title: A Double-blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression | |||||||||||||
| Medical condition: Bipolar I Disorder Major Depressive Episode | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-000290-32 | Sponsor Protocol Number: SOLTI-0701 | Start Date*: 2007-05-27 | |||||||||||
| Sponsor Name:SOLTI | |||||||||||||
| Full Title: A Multinational Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo when Administered in Combination with Capecitabine in Patients with Local... | |||||||||||||
| Medical condition: Locally Advanced or Metastatic Breast Cancer Cáncer de Mama Localmente Avanzado o Metastásico | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-004484-31 | Sponsor Protocol Number: NN9931-4492 | Start Date*: 2019-05-13 | ||||||||||||||||
| Sponsor Name:Novo Nordisk A/S | ||||||||||||||||||
| Full Title: Investigation of efficacy and safety of semaglutide s.c. once-weekly versus placebo in subjects with non-alcoholic steatohepatitis and compensated liver cirrhosis | ||||||||||||||||||
| Medical condition: Non-alcoholic steatohepatitis Compensated liver cirrhosis | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) FR (Completed) ES (Ongoing) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2009-009956-20 | Sponsor Protocol Number: ICG-REG_01 | Start Date*: 2009-05-29 | |||||||||||
| Sponsor Name:Free State of Bavaria rep. by the Univ. of Regensburg, rep. by the Regensburg Univ. Hospital | |||||||||||||
| Full Title: Prospective, randomized, controlled, mono-centric, two-armed, single-blinded pilot study for the treatment of venous and capillary vascular malformations by Indocyanine Green-augmented laser therapy | |||||||||||||
| Medical condition: venous and capillary vascular malformations | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-003614-40 | Sponsor Protocol Number: SVB800_001 | Start Date*: 2019-06-06 | |||||||||||
| Sponsor Name:Bracco Imaging Spa | |||||||||||||
| Full Title: MOLECULAR FLUORESCENCE-GUIDED SURGERY USING BEVA800 FOR THE ASSESSMENT OF TUMOR MARGINS DURING BREAST CONSERVING SURGERY OF PATIENTS WITH PRIMARY BREAST CANCER (MARGIN-II) | |||||||||||||
| Medical condition: Primary breast cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-001634-36 | Sponsor Protocol Number: SARCOVID | Start Date*: 2020-04-09 |
| Sponsor Name:Rosario García de Vicuña | ||
| Full Title: Randomized open pilot study to evaluate the efficacy of subcutaneous sarilumab in patients with moderate-severe COVID-19 infection. | ||
| Medical condition: COVID-19 infection requiring hospitalization | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.